Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 106662)
Heart and Stroke Foundation of Canada (G-13-003029)
Ontario Research Fund grant (ORF-RE 04-47)
Text and Data Mining valid from 2019-10-30
Received: 23 June 2019
Accepted: 20 September 2019
First Online: 30 October 2019
Ethics approval and consent to participate
: The University of Calgary Conjoint Health Research Ethics Board approved the study (Ethics ID #REB15–1340) and all subjects provided written consent to participate.
: Written informed consent for publication was also obtained from all participants in the study.
: SHS is co-Founder and Chief Scientific Officer of BKIN Technologies, which commercializes the KINARM robot.